Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"Observational, Retrospective and Prospective, Non-interventional, Multicentre National Registry-based Study to Collect Information on the Use of Genomic Testing in the Management of Early Stage HR+/HER2- Breast Cancer"

NCT06871501 is registered in ClinicalTrials.gov with Consorzio Oncotech as lead sponsor.

NCT NCT06871501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06871501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"Observational, Retrospective and Prospective, Non-interventional, Multicentre National Registry-based Study to Collect Information on the Use of Genomic Testing in the Management of Early Stage HR+/HER2- Breast Cancer"
Lead sponsor
Consorzio Oncotech
Phase
Observational
Overall status
Not yet recruiting
Start date
March 31, 2025
Completion date
November 30, 2026
Enrollment
1,000 (estimated)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer